HOME >> MEDICINE >> NEWS
NIAID initiates trial of experimental avian flu vaccine

Fast-track recruitment has begun for a trial to investigate the safety of a vaccine against H5N1 avian influenza, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), announced today.

Sites in Rochester, NY, Baltimore and Los Angeles will enroll a total of 450 healthy adults. The clinical sites are part of the NIAID-sponsored Vaccine and Treatment Evaluation Units (VTEU).

"While there have been relatively few cases worldwide of H5N1 avian influenza infection in humans, the public health community is concerned that the virus will develop the capability of efficiently spreading from human to human and thus create a risk for a worldwide pandemic," says NIAID Director Anthony S. Fauci, M.D.

"NIAID has supported research on H5N1, the strain responsible for this deadly form of avian influenza, since 1997 when the first cases in humans were reported. The initiation of this vaccine trial marks a key advance in our efforts to prepare to respond to an avian flu pandemic," adds Dr. Fauci.

Sanofi pasteur, Swiftwater, PA, manufactured the trial vaccine, which is an inactivated vaccine made from an H5N1 virus isolated in Southeast Asia in 2004. Sanofi pasteur, formerly Aventis Pasteur, was awarded a contract by NIAID to manufacture the H5N1 vaccine in May 2004.

This Phase I trial will test the vaccine's safety and ability to generate an immune response in 450 healthy adults aged 18 to 64. If the vaccine is shown to be safe in adults, there are plans to test it in other populations, such as the elderly and children.

H5N1 avian influenza leads to severe disease in both birds and humans. Between January 2004 and March 11, 2005, there were 69 confirmed cases of and 46 deaths from H5N1 infection in humans reported to the World Health Organization. To date, there has been a small number of cases where human-to-human transmission of the virus may have occurred. However, public
'"/>

Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
23-Mar-2005


Page: 1 2

Related medicine news :

1. NIAID seeks applicants to lead clinical trials units for revamped HIV/AIDS networks
2. NIAID begins enrolling volunteers for novel HIV vaccine study
3. NIAID-sponsored clinical trial aims to boost flu vaccine supply
4. NIAID seeks applicants to lead revamped HIV/AIDS clinical trials networks
5. NIAID launches influenza genome sequencing project
6. NIAID launches program to improve medical tools against emerging infectious diseases
7. NIAID forms network to tackle potentially fatal reaction to smallpox vaccine
8. NIAID rotavirus vaccine licensed for commercialization
9. Second NIAID SARS vaccine candidate helps mice fend off SARS
10. NIAID vaccine protects against SARS virus infection in mice
11. NIAID Ebola vaccine enters human trial

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/10/2018)... ... ... In the aftermath of 1960s feminist movement, multiple generations of men have suffered ... movement. To redress the balance, author Steve Clarke wrote “The Man Book,” a guide ... were always meant to be by highlighting the qualities and behaviors of a Man ...
(Date:12/10/2018)... ... December 10, 2018 , ... The most active U.S. markets in ... again host the CWCBExpo (Cannabis World Congress) leading B2B trade shows and conferences. ... May 29-June 1, 2019, Jacob K. Javits Convention Center, New York, NY , 6th ...
(Date:12/8/2018)... (PRWEB) , ... December 07, 2018 , ... ... , At this critical juncture in world affairs, U.S. leadership and funding at ... relationship over the years—great strides in reducing extreme poverty and advancing global health ...
(Date:12/6/2018)... ... 06, 2018 , ... Tea infusions made from two species ... drug most commonly used against the ailment—and with no adverse side effects—in a ... including a professor and two research associates at Worcester Polytechnic Institute (WPI), say ...
(Date:12/5/2018)... ... December 05, 2018 , ... Adam Devlin , co-founder ... to serve on Philadelphia Mayor James F. Kenney’s Commission on People with Disabilities. ... with a cognitive or physical disability. Devlin serves as the chair of the ...
Breaking Medicine News(10 mins):
(Date:12/5/2018)... ... December 04, 2018 , ... Florida Hospital West Florida ... quality. Today, the prestigious Leapfrog Group, a national nonprofit health care ratings organization, ... Heartland Medical Center Sebring, Florida Hospital Wesley Chapel and Florida Hospital Zephyrhills all ...
(Date:12/5/2018)... (PRWEB) , ... December 05, 2018 , ... Two women ... $1 million Sanford Lorraine Cross Award. , Jean Bennett, M.D., Ph.D., and Katherine ... of blindness, accepted the award on Dec. 4 at Sanford Health, headquartered in Sioux ...
(Date:11/29/2018)... ... November 29, 2018 , ... Designs for Health ... launch of the Annatto-E™ product line, containing unique and natural vitamin E tocotrienols ... DFH’s new Annatto-E™ products are available in three dosages of 75mg (with black ...
Breaking Medicine Technology:
Cached News: